Gene · 81029
Papers1,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives. | Diagnostics (Basel) | 2023 | 37835765 | PubTator, text mining | PubMed |
| Clinical Potential of Cellular Material Sources in the Generation of iPSC-Based Products for the Regeneration of Articular Cartilage. | Int J Mol Sci | 2023 | 37833856 | PubTator, text mining | PubMed |
| The odontoblastic differentiation of dental mesenchymal stem cells: molecular regulation mechanism and related genetic syndromes. | Front Cell Dev Biol | 2023 | 37818127 | PubTator, text mining | PubMed |
| Paeoniflorin shows chondroprotective effects under IL-1β stress by regulating circ-PREX1/miR-140-3p/WNT5B axis. | J Orthop Surg Res | 2023 | 37817257 | PubTator, text mining | PubMed |
| Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren's syndrome. | iScience | 2023 | 37810210 | PubTator, text mining | PubMed |
| Cigarette smoke restricts the ability of mesenchymal cells to support lung epithelial organoid formation. | Front Cell Dev Biol | 2023 | 37795260 | PubTator, text mining | PubMed |
| Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis. | Cell Mol Biol Lett | 2023 | 37770821 | PubTator, text mining | PubMed |
| Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression. | Cancer Discov | 2023 | 37768068 | PubTator, text mining | PubMed |
| Lung extracellular matrix modulates KRT5+ basal cell activity in pulmonary fibrosis. | Nat Commun | 2023 | 37758700 | PubTator, text mining | PubMed |
| IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner. | Clin Transl Med | 2023 | 37743642 | PubTator, text mining | PubMed |
| Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer. | Explor Target Antitumor Ther | 2023 | 37720350 | PubTator, text mining | PubMed |
| Monolayer platform to generate and purify primordial germ-like cells in vitro provides insights into human germline specification. | Nat Commun | 2023 | 37709760 | PubTator, text mining | PubMed |
| Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer. | Cells | 2023 | 37681914 | PubTator, text mining | PubMed |
| RNF43 and ZNRF3 in Wnt Signaling - A Master Regulator at the Membrane. | Int J Stem Cells | 2023 | 37643759 | PubTator, text mining | PubMed |
| The functional effects of Piezo channels in mesenchymal stem cells. | Stem Cell Res Ther | 2023 | 37633928 | PubTator, text mining | PubMed |
| Adipocyte regulation of cancer stem cells. | Cancer Sci | 2023 | 37622414 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation and transcriptome expression profiles of peripheral blood mononuclear cells in patients with systemic sclerosis with interstitial lung disease. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2023 | 37587067 | PubTator, text mining | PubMed |
| FOXO1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells. | FEBS Open Bio | 2023 | 37584250 | PubTator, text mining | PubMed |
| Predicting congenital renal tract malformation genes using machine learning. | Sci Rep | 2023 | 37580336 | PubTator, text mining | PubMed |
| Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. | Cells | 2023 | 37566084 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81029/papers?page=5